keyboard_backspaceBack to listing
venture-img

Cellix Bio

Bio-Pharmaceutical

Cellix Bio

Keywords:

Bio-Pharmaceutical, Drug Design and Development, Neurological Diseases, Inflammatory Diseases, Metabolic Diseases, Therapies and Treatments, Research and Innovation, Patents, ACHANNACHOWDARY VALLURI, MAHESH KANDULA, Prestigious Educational Backgrounds (IIT, Stanford, Babson College, University of Edinburgh), Investment and Funding

SUMMARY

Cellix Bio is a biopharmaceutical company that specializes in drug discovery and development. The company stands out for its use of an AI platform named Synergix, which aids in drug design, focusing on creating new molecular entities that demonstrate synergistic pharmacology. This innovative approach is pivotal in Cellix Bio's mission to develop therapies for a wide range of diseases, including oncological, neurological, inflammatory, metabolic, and others. Cellix Bio's mission is strongly aligned with its technological innovation. It works closely with the scientific community, universities, and research institutions to advance and build the value of its Synergix AI™ technology. The company is dedicated to developing promising intellectual property and creating value for stakeholders and investors. A key aspect of Cellix Bio's approach is its emphasis on addressing unmet medical needs across various therapeutic areas such as neurology, ophthalmology, dermatology, oncology, inflammation, and metabolic diseases. As a subsidiary of Cellix Bio, Cellix Bio Pharma plays a significant role in the parent company's mission. It is a global contract research organization (CRO) focusing on the development of pharmaceutical formulations. Cellix Bio Pharma's expertise in drug discovery, development, and delivery technologies, combined with a strong product development and regulatory filings pipeline in various stages of development, complements the overarching goals of Cellix Bio. The acquisition of Avaca Pharma further strengthens Cellix Bio Pharma's capabilities in pharmaceutical development.

PRODUCTS

Neurological, Inflammatory, Metabolic diseases

SERVICES

Drug Design and Development, Therapies for Neurological Diseases, Therapies for Inflammatory Diseases, Therapies for Metabolic Diseases

FOUNDER DETAILS
Mahesh Kandula

18 years of scientific and entrepreneurial

ABOUT

Cellix Bio, founded in 2014 in Hyderabad, is a bio-pharmaceutical company specializing in drug design and development. It focuses on therapies for neurological, inflammatory, and metabolic diseases, leveraging innovative research and development strategies.

COMPANY TYPE
Private Limited Company
SERVICE VERTICALS
TECHNOLOGY
THERAPEUTIC AREAS
VALUE OFFERING
LOCATION

Hyderabad, Telangana, India

TARGET USERS
  • Healthcare Professionals and Researchers
  • Pharmaceutical Companies and Biotech Industry
  • Academic and Research Institutions
INCORPORATION DATE

21 May 2014

STATE/CITY

Telangana, India

INDEX DATA USAGE NOTICE

At Mocero Health, we are committed to maintaining the trust and confidence of our visitors and users. This Index Data Usage Notice explains how we collect, use, and share data related to the various indices and aggregated metrics presented on our site. Index data on Mocero Health is generated through a combination of proprietary algorithms, user interactions, and publicly available health data. This may include, but is not limited to, health condition prevalence rates, treatment effectiveness scores, healthcare facility ratings, and user search trends. If you have concerns about how your data is used or wish to exercise your rights, please contact us at +91-9500115161. By using Mocero Health, you acknowledge and agree to the collection, use, and sharing of index data as described in this notice.

CONTENT DISCLAIMER

The information provided on this website is intended for general and educational purposes only. We reserve the right to modify this content policy at any time. Changes will be effective immediately upon posting the revised policy. Your continued use of the platform after any changes signifies your agreement to the new terms. If you have concerns about how your data is used or wish to exercise your rights, please contact us at +91-9500115161. By using this site, you acknowledge and agree that you have read and understood this Content Disclaimer.

News

Stay up-to-date with news about health-tech startups, compiled and presented in a centralized platform.